Association between clinical factors and dose modification strategies in the treatment with ustekinumab for moderate-to-severe plaque psoriasis

1. Romero-Jimenez, R.M.
2. Escudero-Vilaplana, V.
3. Baniandres Rodriguez, O.
4. García Martín, E.
5. Mateos Mayo, A.
6. Sanjurjo Saez, M.